Remnant cholesterol and systemic inflammation as synergistic predictors of cancer risk: A 16‐year prospective cohort study
RC and systemic inflammation act synergistically and bidirectionally to increase cancer risk, supporting a metabolic-inflammatory axis in carcinogenesis. These findings identify novel, potentially modifiable targets for early cancer risk stratification and prevention.
Authors
- Shuohua Chen (ORCID: https://orcid.org/0000-0002-6274-7471)
- Shouling Wu (ORCID: https://orcid.org/0000-0001-7095-6022)
- Hongxue Xu (ORCID: https://orcid.org/0009-0000-1722-0219)
- Peipei Liu (ORCID: https://orcid.org/0000-0001-8374-9823)
- Guodong Wang (ORCID: https://orcid.org/0000-0002-0422-8999)
- Xuemei Zhang (ORCID: https://orcid.org/0000-0003-3970-7110)
Institutions
- North China University of Science and Technology (CN)
- Kailuan General Hospital (CN)
Publication Details
- Journal
- Cancer
- Published
- 2025-09-18
- DOI
- https://doi.org/10.1002/cncr.70096
- Citations
- 1
- Primary Topic
- Cancer, Lipids, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.94